<![CDATA[Merz Pharmaceuticals GmbH 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=35386>Sat, 16 May 2026 23:53:59 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Teijin Receives Marketing Approval for Merz’s Xeomin® Botulinum Toxin Type A in Japan]]>https://www.newswire.co.kr/newsRead.php?no=907058Mon, 29 Jun 2020 18:00:00 +0900<![CDATA[테이진, 멀츠 제오민 보툴리눔 톡신 A형의 일본 내 판매 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=907059Mon, 29 Jun 2020 18:00:00 +0900